Home-Based DBS Monitoring Identifies Early β-Cell Changes in USTEKID Read more about Home-Based DBS Monitoring Identifies Early β-Cell Changes in USTEKID
T2DM May Worsen Survival Outcomes With ICIs in Lung Cancer Read more about T2DM May Worsen Survival Outcomes With ICIs in Lung Cancer
Dapagliflozin Linked to Preserved HRV During GLP-1 RA Therapy Tags SGLT-2 Inhibitor Read more about Dapagliflozin Linked to Preserved HRV During GLP-1 RA Therapy
GLP-1 RAs Linked to Lower Mortality in Breast Cancer Tags GLP-1 agonists Read more about GLP-1 RAs Linked to Lower Mortality in Breast Cancer
Dapagliflozin-Linagliptin Combination Improved TIR in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about Dapagliflozin-Linagliptin Combination Improved TIR in T2DM
LAP Thresholds Identified MASLD Risk in Adults With T2DM Read more about LAP Thresholds Identified MASLD Risk in Adults With T2DM
SGLT2 Inhibitors Show No Increased Cancer Risk Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Show No Increased Cancer Risk
CGM Variability Metrics Enhance HbA1C Estimation in T2DM Tags Continuous glucose monitoring (CGM) hBA1c Read more about CGM Variability Metrics Enhance HbA1C Estimation in T2DM
T2DM Subtypes Showed Distinct Dementia and Stroke Risks Tags Diabetic Neuropathy Stroke Read more about T2DM Subtypes Showed Distinct Dementia and Stroke Risks
CXCL10 May Help Differentiate LADA From T2DM Read more about CXCL10 May Help Differentiate LADA From T2DM
